Jubilant Life Sciences

GPTKB entity

Properties (49)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:HollisterStier
gptkb:Jubilant_Pharma
Draximage
gptkbp:awards Various industry awards for excellence
gptkbp:CEO gptkb:Shyam_S._Bhartia
gptkbp:clinicalTrials Conducts numerous clinical trials globally
Phase I to Phase IV studies
Supports drug development from concept to market.
gptkbp:communityEngagement Various CSR initiatives
gptkbp:employees Over 7,000
gptkbp:financialPerformance Listed_on_stock_exchanges_in_India
gptkbp:firstDeployment Diverse workforce from various countries
gptkbp:founded 1978
gptkbp:founder gptkb:Shyam_S._Bhartia
gptkbp:headquarters gptkb:Noida,_India
https://www.w3.org/2000/01/rdf-schema#label Jubilant Life Sciences
gptkbp:industry Pharmaceuticals
gptkbp:innovation Focus on developing new therapies
gptkbp:investmentFocus Invests in R&D and technology upgrades
gptkbp:manufacturer gptkb:Noida,_India
gptkbp:market Global presence in over 100 countries
gptkbp:marketingStrategy Pharmaceuticals
Radiopharmaceuticals
Contract_Research_and_Manufacturing_Services
Life_Sciences_Ingredients
gptkbp:partnerships Various global pharmaceutical companies
Academic institutions for research collaboration
gptkbp:productionCompany Multiple_facilities_in_India_and_abroad
gptkbp:products Formulations
Active_Pharmaceutical_Ingredients_(APIs)
Contract_Manufacturing_Services
gptkbp:regulatoryCompliance FDA,_EMA,_and_other_global_standards
gptkbp:research_areas Cardiology
Oncology
Diabetes
Neurology
Infectious Diseases
gptkbp:researchAndDevelopment Focus on innovative drug delivery systems
gptkbp:revenue $1 billion (2021)
gptkbp:services Regulatory Affairs
Drug Discovery
Clinical_Research
gptkbp:stockExchange gptkb:BSE
NSE
gptkbp:subsidiary gptkb:Jubilant_Pharma_Limited
gptkb:Jubilant_HollisterStier
gptkbp:sustainabilityInitiatives Commitment to sustainable practices
gptkbp:website www.jubilantlifesciences.com